Evidence map›Paper›PMID 40071932›Full record

ArticleNucleic acids research2025

Deciphering the landscape of cis-acting sequences in natural yeast transcript leaders.

Christina Akirtava, Gemma E May, C Joel McManus

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Christina AkirtavaDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, United States.
Gemma E MayDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, United States.
C Joel McManusDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, United States.ORCID 0000-0002-6605-2642

Funding

Regulation of mRNA translation by cis-acting sequences and trans-acting factorsR35GM145317 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI Charles Joel McManus · 2022 to 2026
$1.9M
NIGMS NIH HHS R35 GM145317
6 · The paper itself

Abstract

Protein synthesis is a vital process that is highly regulated at the initiation step of translation. Eukaryotic 5' transcript leaders (TLs) contain a variety of cis-acting features that influence translation and messenger RNA stability. However, the relative influences of these features in natural TLs are poorly characterized. To address this, we used massively parallel reporter assays (MPRAs) to quantify RNA levels, ribosome loading, and protein levels from 11,027 natural yeast TLs in vivo and systematically compared the relative impacts of their sequence features on gene expression. We found that yeast TLs influence gene expression over two orders of magnitude. While a leaky scanning model using Kozak contexts (-4 to +1 around the AUG start) and upstream AUGs (uAUGs) explained half of the variance in expression across TLs, the addition of other features explained ∼80% of gene expression variation. Our analyses detected key cis-acting sequence features, quantified their effects in vivo, and compared their roles to motifs reported from an in vitro study of ribosome recruitment. In addition, our work quantitated the effects of alternative transcription start site usage on gene expression in yeast. Thus, our study provides new quantitative insights into the roles of TL cis-acting sequences in regulating gene expression.

Indexed as

5' Untranslated RegionsGene Expression Regulation, FungalRNA, MessengerSaccharomyces cerevisiaeProtein BiosynthesisRibosomesRNA, FungalRNA Stability5' Untranslated RegionsRNA, FungalRNA, Messenger

Identifiers

PMID40071932
PMCPMC11897887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.